Venus thromboembolism and risk stratification and hematological malignancies
In recent years, the incidence of venous thromboembolism (VTE) has been rising in patients with cancer. A Danish cohort...
Thrombosis and cancer
Diagnosis, screening, and prevention of cancer-associated thrombosis
The tight association between malignancies and hypercoagulation was highlighted almost a century ago by the...
PODCAST. Building a CAT Clinic: Real-World Systems Approaches to Prevention and Treatment. Waiting for ICTHIC 2022
Cancer-associated thrombosis (CAT) is an important and increasingly common complication of cancer and cancer...
How to improve patient’s awareness about the risk of cancer-associated thrombosis
Although patients with cancer have a four-to-five-fold increased risk of venous thromboembolism (VTE) compared with the...
PODCAST. Thrombosis and coagulation in the contemporary management of breast cancer. Waiting for ICTHIC 2022
Breast cancer is the most commonly diagnosed cancer in women accounting for a quarter of cancer cases worldwide. This...
Prediction of disease progression and mortality in patients with metastatic gastrointestinal cancer: the role of thrombin generation and D-dimer
Gastrointestinal (GI) cancers represent 26% of the global cancer incidence and more than one-third of all...
Thrombosis management in hematological cancers vs solid tumors: what are the differences?
During the ICTHIC webinar “CAT management: challenges in different cancer populations,” Prof Darko Antic...
Management and safety considerations in specific sub-populations of patients with cancer
During the ICTHIC webinar “CAT management: challenges in different cancer populations”, Prof Walter Ageno gave a...
The role of neutrophils in cancer and thrombosis. Waiting for ICTHIC 2022
The role of neutrophils in innate immunity is well known, but only recently they have been linked to other phenomena...
Low-dose apixaban as secondary prophylaxis in patients with cancer: is it safe?
Recurrent venous thromboembolism (VTE) and major bleeding are the two major challenges in managing cancer-associated...